- Medicine Access and Rational Use > Pricing
- Medicine Access and Rational Use > Supply Management
- Quality and Safety: Medicines > Quality Assurance
- Health Technology Management > Procurement
- Diagnostics and Laboratory Technology > HIV Testing Guidance
(2005; 85 pages)
Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS
A JOINT UNICEF - UNAIDS - WHO - MSF PROJECT
WHO Library Cataloguing-in-Publication Data
Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS/a joint UNICEF, UNAIDS, WHO, MSF project. - 76th ed.
1. Pharmaceutical preparations - supply and distribution 2. Reagent kits, Diagnostic - supply and distribution 3. HIV infections - diagnosis 4. HIV infections - drug therapy 5. Price lists 6. Catalogs, Drug I. World Health Organization.
ISBN 92 4 159334 2 (LC/NLM classification: QV 772)
This report is also available
On the following web pages:
WHO/Department of Medicines Policy and Standards: www.who.int/medicines
WHO/AIDS Medicines and Diagnostics Service (AMDS): www.who.int/3by5/amds/en
WHO/Department of Essential Health Technologies: www.who.int/diagnostics_laboratory
Médecins Sans Frontières (MSF): www.accessmed-msf.org
Or by contacting:
Pharmaceuticals and Micronutrients Team
Department of Policy, Evidence and Partnerships, UNAIDS
Medicines Policy and Standards (PSM), World Health Organization
Campaign for Access to Essential Medicines, Médecins Sans Frontières
Information on HIV/AIDS diagnostic support, HIV test kit evaluations and bulk procurement is available on the WHO/Department of Essential Health and Technologies website: www.who.int/eht
Information on HIV/AIDS and substance abuse is available from www.who.int/substance_abuse
© World Health Organization, United Nations Children’s Fund, Joint United Nations Programme on HIV/AIDS (UNAIDS), Médecins Sans Frontières, 2005.
All rights reserved. Published by WHO on its own behalf and for UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières.
WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières, have made every effort to ensure the accuracy of price, supplier, and other information presented in this report. However, the reader's attention is drawn to the introduction, which describes the specific sources and limitations of information provided in this report.
The reader's attention is also drawn to the importance of quality assurance for pharmaceutical products. Licensing authorities in the respective countries of manufacture are responsible for the review and approval of the detailed composition and formulation when authorizing a pharmaceutical product to be marketed, including the specifications of its ingredients, as submitted by the manufacturer of the dosage form, and to oversee compliance with Good Manufacturing Practice requirements as recommended by WHO. This publication is intended to provide information on the prices and sources of products regardless of quality, efficacy and safety. Annexes 2A and 2B provide information on the countries in which the products listed in this publication are currently registered and on those products that have been found to meet WHO recommended standards under the WHO Prequalification Procedure. It should be noted, however, that this information is subject to change, and should therefore be verified before a decision on procurement from a particular source is taken.
This list is not an exhaustive list of all available products for the diagnosis and treatment of HIV/AIDS-related illness. It includes only those products which were known to WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières as being commercially available at the time of publication and for which the manufacturer has (on a voluntary basis) agreed to complete a questionnaire and provide related information and documentation. The manufacturers listed will be regularly requested to provide UNICEF with updated information and it is hoped that the number of manufacturers reached and participating will increase over time. This publication does not constitute an endorsement or warranty of the fitness of any product for a particular purpose. This publication is not based on an active assessment of, and does not therefore constitute an acceptance or recommendation in regard to, any product's quality, safety or efficacy for the treatment of HIV/AIDS-related illness. WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières do not furthermore warrant that the use of the products mentioned is in accordance with the national laws and regulations of any country, including but not limited to patent laws. It is recommended that readers intending to use this publication familiarize themselves with all pertinent aspects, such as quality, safety and efficacy as well as quantification, patents, financial stability and standing of the supplier, ability to supply the required quantities, delivery time and other related aspects.
Bearing in mind that the data and information provided for a product depends largely on the manufacturer, these data and information are being provided as is, and WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières make no representations or warranties, either express or implied, as to their accuracy, completeness or fitness for a particular purpose. WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières accept no responsibility or liability for the reliance on, or use of, such data and information.
This list may not be used by manufacturers and suppliers for commercial or promotional purposes. The mention of specific companies and certain of their products does not imply that they are recommended by the WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières in preference to others of a similar nature that are not mentioned.
The designations employed and the presentation of the material in this report, including tables and maps, do not imply the expression of any opinion whatsoever on the part of the WHO, UNICEF, the UNAIDS Secretariat, and Médecins Sans Frontières concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent border lines for which there may not yet be full agreement.
Designed by minimum graphics
Printed in France